Tenosynovial Giant Cell Tumor
Tenosynovial Giant Cell Tumor (TGCT) is a rare tumor that arises from the synovial tissue, often affecting joints and tendons, leading to pain, swelling, and limited movement in the affected area.
Tenosynovial Giant Cell Tumor: Study of ABSK021
We are investigating a new treatment, ABSK021, for patients with Tenosynovial Giant Cell Tumor to see if it is safe and effective compared to a placebo. The study will also assess how it affects tumor size and patient mobility.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have a tumor called TGCT that cannot be treated with surgery right now?
- Have you had any major surgery or cancer treatment in the last 4 weeks?
- Do you have any known allergies to medications or treatments?
- Do you have any serious heart problems or significant heart disease?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Absk021
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Bergonie
Oncologie Medicale
Bordeaux, France
Centre Oscar Lambret
Cancérologie Sénologique
Loos, France
Istituto Ortopedico Rizzoli
Osteoncologia, Sarcomi dell'Osso e dei Tessuti Molli e Terapie Innovative
Bologna, Italy
Sponsor: Abbisko Therapeutics Co. Ltd.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.